Additionally, in NSCLC, a meta-analysis of 60 studies found that patients with higher TIL infiltration had significantly improved overall survival, particularly among CD8+, CD3+, and CD4+ subtypes (102). This evidence concerns the gene CD8A and non-small cell lung carcinoma.